New IBM Watson and Medtronic App Anticipates Low Blood Glucose Levels for People with Diabetes
Can a new app jointly developed by IBM with its Watson AI technology in partnership with the medical device maker Medtronic provide a new form of support for people with diabetes by safely avoiding low blood glucose (BG) levels (called hypoglycemia), in advance? If so, and assuming regulatory approval, this technology could potentially be a […]